Literature DB >> 27718640

Targeted upper-limb Wii-based Movement Therapy also improves lower-limb muscle activation and functional movement in chronic stroke.

Terry Trinh1,2, Christine T Shiner1,2, Angelica G Thompson-Butel1,2, Penelope A McNulty1,2.   

Abstract

PURPOSE: Post-stroke hemiparesis may manifest as asymmetric gait, poor balance, and inefficient movement patterns. We investigated improvements in lower-limb muscle activation and function during Wii-based Movement Therapy (WMT), a rehabilitation program specifically targeting upper-limb motor-function.
METHODS: Electromyography (EMG) was recorded bilaterally from tibialis anterior (TA) in 20 stroke patients during a 14-day WMT program. EMG amplitude and burst duration were analyzed during stereotypical movement sequences of WMT activities. Functional movement ability was assessed pre- and post-therapy including 6-min walk test (6MWT), stair-climbing speed, and Wolf Motor Function Test timed-tasks.
RESULTS: TA EMG burst duration during Wii-golf increased by 30% on the more-affected side (p = 0.04) and decreased by 28% on the less-affected side. Patients who did not step during Wii-tennis had a 16% decrease in more-affected TA burst sum (p = 0.047) resulting in more symmetrical activation ratio at late-therapy, with the ratio changing from 3.24 ± 2.25 to 0.99 ± 0.11 (p = 0.047). Six-minute walk and stair-climbing speed improved (p = 0.005 and 0.03, respectively), as did upper-limb movement (p ≤ 0.001).
CONCLUSION: This study provides physiological evidence for lower-limb improvements with WMT. Different patterns of muscle activation changes were evident across the WMT activities. Despite the relatively good pre-therapy lower-limb function, muscle activation and symmetry improved significantly with upper-limb WMT. Implications for rehabilitation WMT is an upper-limb neurorehabilitation program that also improves lower-limb motor-function. We report a shift towards more symmetrical muscle activation of tibialis anterior on the more- and less-affected sides that were reflected in increased distance walked during the 6MWT. The use of standing during therapy not only improves lower-limb function but also permits larger and more powerful upper-limb movements. Targeted upper-limb rehabilitation can also significantly improve mobility and balance, whether dynamic or static, that should reduce the risk of falls post-stroke.

Entities:  

Keywords:  activities of daily living; balance; electromyography; muscle symmetry; walking

Mesh:

Year:  2016        PMID: 27718640     DOI: 10.1080/09638288.2016.1213892

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  4 in total

1.  A Longitudinal Electromyography Study of Complex Movements in Poststroke Therapy. 2: Changes in Coordinated Muscle Activation.

Authors:  Negin Hesam-Shariati; Terry Trinh; Angelica G Thompson-Butel; Christine T Shiner; Penelope A McNulty
Journal:  Front Neurol       Date:  2017-07-20       Impact factor: 4.003

2.  A Longitudinal Electromyography Study of Complex Movements in Poststroke Therapy. 1: Heterogeneous Changes Despite Consistent Improvements in Clinical Assessments.

Authors:  Negin Hesam-Shariati; Terry Trinh; Angelica G Thompson-Butel; Christine T Shiner; Penelope A McNulty
Journal:  Front Neurol       Date:  2017-07-28       Impact factor: 4.003

3.  Comparative Effectiveness of Robot-Assisted Training Versus Enhanced Upper Extremity Therapy on Upper and Lower Extremity for Stroke Survivors: A Multicentre Randomized Controlled Trial.

Authors:  Yingnan Lin; Qin-Ying Li; Qingming Qu; Li Ding; Zhen Chen; Fubiao Huang; Shihong Hu; Wei Deng; Fengxian Guo; Chuankai Wang; Panmo Deng; Li Li; Hao Jin; Cong Gao; Beibei Shu; Jie Jia
Journal:  J Rehabil Med       Date:  2022-08-26       Impact factor: 3.959

4.  Alterations in Spectral Attributes of Surface Electromyograms after Utilization of a Foot Drop Stimulator during Post-Stroke Gait.

Authors:  Rakesh Pilkar; Arvind Ramanujam; Karen J Nolan
Journal:  Front Neurol       Date:  2017-08-29       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.